- Home
- DNTH vs SNDR Comparison
DNTH vs SNDR Comparison
Compare DNTH & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | SNDR |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.3B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DNTH | SNDR |
|---|---|---|
| Price | $88.51 | $30.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $121.00 | $27.83 |
| AVG Volume (30 Days) | 523.2K | ★ 879.4K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $2,036,000.00 | ★ $5,674,300,000.00 |
| Revenue This Year | N/A | $5.11 |
| Revenue Next Year | $29.48 | $6.05 |
| P/E Ratio | ★ N/A | $53.10 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $16.77 | $20.11 |
| 52 Week High | $96.50 | $33.34 |
Technical Indicators
Market Signals| Indicator | DNTH | SNDR |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 57.90 |
| Support Level | $33.94 | $26.88 |
| Resistance Level | $96.50 | $30.83 |
| Average True Range (ATR) | 4.02 | 1.07 |
| MACD | -1.21 | 0.04 |
| Stochastic Oscillator | 45.82 | 46.44 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, LTL carriers, railroads, ocean carriers, airlines to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload, Intermodal, Logistics and other. It generates maximum revenue from the Truckload segment.